With our incredible universities, educated workforce and geographic location, I firmly believe Connecticut can be the next ...

KEY TAKEAWAYS French drugmaker Sanofi said Monday it has agreed to acquire Blueprint Medicines for up to $9.5 billion, ...

Sanofi agreed to buy Blueprint Medicines Corp. for at least $9.1 billion as the French drugmaker expands further in rare ...

Epidermolysis bullosa is a rare and severe skin disease where patients have fragile skin that blisters and tears. A Mt.

As Houston's life sciences ecosystem continues to grow, one local investment fund is making a bold move to increase its ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...

In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...

Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and ...

In partnership with the Silicon Valley Business Journal, we'll honor the Bay Area's top companies recognized as the Best ...

For investors still seeking companiies with attractive long-term prospects, let's consider two in the biotech industry: ...

In conversation with Fierce Biotech’s Chris Hayden, Austin Read, head of PPD™ CorEvitas™ Precision Medicine, Thermo Fisher ...